Live attenuated oral vaccine, age and anti-Vi antibody status at baseline significantly affect attack rate in a human Salmonella Typhi challenge model

Live attenuated oral vaccine, age and anti-Vi antibody status at baseline significantly affect attack rate in a human Salmonella Typhi challenge model

Bibliographic Details
Main Authors:	Darton, T, Jones, C, Waddington, C, Blohmke, C, Peters, A, Haworth, K, Green, C, Jeppesen, C, Moore, M, Thompson, B, John, T, Kingsley, R, Yu, L, Voysey, M, Lockhart, S, Farrar, J, Sztein, M, Angus, B, Levine, M, Pollard, A
Format:	Conference item
Language:	English
Published:	Elsevier 2015

Similar Items

Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model.
by: McArthur, M, et al.
Published: (2015)

Quantification of antibody secreting cell responses in a human challenge model of Salmonella Typhi infection
by: Jones, C, et al.
Published: (2012)

Importance of Salmonella Typhi-Responsive CD8+ T Cell Immunity in a Human Typhoid Fever Challenge Model
by: Fresnay, S, et al.
Published: (2017)

Salmonella Typhi-specific multifunctional CD8+ T cells play a dominant role in protection from typhoid fever in humans
by: Fresnay, S, et al.
Published: (2016)

Demonstration of primary and asymptomatic DNAaemia in participants challenged with Salmonella Typhi (Quailes strain) during the development of a human model of typhoid infection
by: Darton, T, et al.
Published: (2012)

Variations in attack rate in a single-blind, dose escalation challenge study of Salmonella Typhi in healthy adult volunteers
by: Waddington, C, et al.
Published: (2012)

Oral challenge with wild-type Salmonella Typhi induces distinct changes in B cell subsets in individuals who develop typhoid disease.
by: Toapanta, F, et al.
Published: (2016)

Oral wild-type Salmonella Typhi challenge induces activation of circulating monocytes and dendritic cells in individuals who develop typhoid disease
by: Toapanta, F, et al.
Published: (2015)

An outpatient, ambulant-design, controlled human infection model using escalating doses of Salmonella Typhi challenge delivered in sodium bicarbonate solution.
by: Waddington, C, et al.
Published: (2014)

Challenge of humans with wild-type Salmonella enterica serovar Typhi elicits changes in the activation and homing characteristics of mucosal-associated invariant T cells.
by: Salerno-Goncalves, R, et al.
Published: (2017)

Human Salmonella Typhi exposure generates differential multifunctional cross-reactive T-cell memory responses against Salmonella Paratyphi and invasive nontyphoidal Salmonella
by: Rapaka, RR, et al.
Published: (2020)

Using a human challenge model of infection to measure vaccine efficacy: a randomised, controlled trial comparing the typhoid vaccines M01ZH09 with placebo and Ty21a
by: Darton, T, et al.
Published: (2016)

Compositional and functional differences in the human gut microbiome correlate with clinical outcome following infection with wild-type Salmonella enterica serovar Typhi
by: Zhang, Y, et al.
Published: (2018)

The impact of vaccination and prior exposure on stool shedding of Salmonella Typhi and Salmonella Paratyphi in 6 controlled human infection studies
by: Gibani, M, et al.
Published: (2018)

Changes in monocyte subsets in volunteers who received an oral wild-type Salmonella Typhi challenge and reached typhoid diagnosis criteria
by: Toapanta, FR, et al.
Published: (2024)

Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model.
by: Gibani, MM, et al.
Published: (2020)

Evolutionary history of Salmonella typhi.
by: Roumagnac, P, et al.
Published: (2006)

Prevalence and genetic analysis of phenotypically Vi- negative Salmonella typhi isolates in children from Kathmandu, Nepal.
by: Pulickal, A, et al.
Published: (2013)

Advancing the management and control of typhoid fever: A review of the historical role of human challenge studies
by: Waddington, C, et al.
Published: (2014)

Quinolone-resistant Salmonella typhi in Vietnam.
by: Parry, C, et al.
Published: (1998)

Antimicrobial Drug Resistance of Salmonella Typhi in Asia
by: Tran, T, et al.
Published: (2008)

Differential killing of Salmonella enterica serovar Typhi by antibodies targeting Vi and lipopolysaccharide O:9 antigen
by: Hart, P, et al.
Published: (2016)

Development of an anti-Salmonella typhi Vi ELISA: assessment of immunocompetence in healthy donors.
by: Ferry, B, et al.
Published: (2004)

Mucosal-Associated Invariant T cells exhibit distinct functional signatures associated with protection against typhoid fever
by: Salerno-Gonçalves, R, et al.
Published: (2022)

Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial
by: Jin, C, et al.
Published: (2017)

Advancing the management and control of typhoid fever: a review of the historical role of human challenge studies.
by: Waddington, C, et al.
Published: (2014)

Evaluation of the clinical and microbiological response to Salmonella Paratyphi A infection in the first paratyphoid human challenge model
by: Dobinson, H, et al.
Published: (2017)

Salmonella typhi bactericidal antibodies reduce disease severity but do not protect against typhoid fever in a controlled human infection model
by: Juel, H, et al.
Published: (2018)

Reply to Farmakiotis et al.
by: Waddington, C, et al.
Published: (2014)

Salmonella Typhi Vi capsule prime-boost vaccination induces convergent and functional antibody responses
by: Dahora, LC, et al.
Published: (2021)

A 23-year retrospective investigation of Salmonella Typhi and Salmonella Paratyphi isolated in a tertiary Kathmandu hospital
by: Zellweger, R, et al.
Published: (2017)

Vi antigen expression in Salmonella enterica serovar Typhi clinical isolates from Pakistan.
by: Wain, J, et al.
Published: (2005)

Characterisation and distribution of a cryptic Salmonella typhi plasmid pHCM2.
by: Kidgell, C, et al.
Published: (2002)

Tubo-ovarian abscess infected by Salmonella typhi.
by: Sharma, P, et al.
Published: (2017)

Antibodies to the Vi capsule of Salmonella Typhi in the serum of typhoid patients and healthy control subjects from a typhoid endemic region.
by: House, D, et al.
Published: (2008)

Blood culture-PCR to optimise typhoid fever diagnosis after controlled human infection identifies frequent asymptomatic cases and evidence of primary bacteraemia.
by: Darton, T, et al.
Published: (2017)

Molecular characterization of the Salmonella enterica serovar Typhi Vi-typing bacteriophage E1.
by: Pickard, D, et al.
Published: (2008)

Early host immune responses in a human organoid-derived gallbladder monolayer to Salmonella Typhi strains from patients with acute and chronic infections: a comparative analysis
by: Rosângela Salerno-Goncalves, et al.
Published: (2024-03-01)

Chronic Salmonella Typhi carriage at sites other than the gallbladder.
by: Seth A Hoffman, et al.
Published: (2023-03-01)

Chronic Salmonella Typhi carriage at sites other than the gallbladder
by: Seth A. Hoffman, et al.
Published: (2023-03-01)